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Respiratory allergy and allergy to foods con-
tinue to be important health issues. There is
evidence to indicate that the incidence of food
allergy around the world is on the rise. Current
estimates indicate that approximately 5% of
young children and 1–2% of adults suffer from
true food allergy (Kagan 2003). Although a
large number of in vivo and in vitro tests exist
for the clinical diagnosis of allergy in humans,
we lack validated animal models of allergenic-
ity. This deﬁciency creates serious problems for
regulatory agencies and industries that must
deﬁne the potential allergenicity of foods before
marketing. The emergence of several biotech-
nologically derived foods and industrial pro-
teins, as well as their potential to sensitize
genetically predisposed populations to develop
allergy, has prompted health ofﬁcials and regu-
latory agencies around the world to seek
approaches and methodologies to screen novel
proteins for allergenicity.
One such approach was proposed initially
by the International Life Science Institute
(ILSI) Allergy and Immunology Institute in
collaboration with the International Food
Biotechnology Council (IFBC) (Metcalfe et al.
1996) and was subsequently modiﬁed by the
Food and Agriculture Organization (FAO)
and the World Health Organization (WHO)
(FAO/WHO 2001). The FAO/WHO 2001
decision tree approach for the evaluation of
allergenicity of genetically modified (GM)
foods recommended a hierarchical approach to
safety assessment (reviewed by Metcalfe et al.
1996; FAO/WHO 2001; Taylor and Hefle
2001). One of the recommendations in this
approach was that animal models, when sufﬁ-
ciently developed and validated, could con-
tribute valuable information to the process of
identifying potential sensitization to food pro-
tein. On the basis of this recommendation,
Health Canada undertook to organize a 2-day
workshop held in Ottawa, 13–14 November
2002. Several prominent research scientists
who are developing animal models of aller-
genicity convened to review the current status
of such models, identify areas that need fur-
ther development, and discuss the role these
models may play in predicting the allergenic
potential of foods, including GM food prod-
ucts. Data were presented on several murine
and nonmurine animal models currently
under development. In addition, emerging
approaches—including the identification of
antigenic epitopes on human allergens using
the human leukocyte antigen (HLA) trans-
genic mouse and a human dendritic cell–based
method to identify CD4+ T-cell epitopes in
potential protein allergens—were presented.
This monograph consists of selected papers
that are relevant to the development of
animal models.
Animal models presently under develop-
ment include the Brown Norway (BN) rat,
the BALB/c mouse, and a transgenic mouse
strain engineered to produce class II HLA
molecules. The potential to sensitize BALB/c
mice systemically via intraperitoneal injec-
tions of proteins has been explored in a series
of experiments detailed by Kimber et al.
(2003). This approach favors the initiation of
vigorous humoral immune responses of the
immunoglobulin (Ig)G and IgE class and
could be a useful model to screen novel pro-
teins for their allergenic potential. The BN
rat is a high Ig (particularly IgE) responder rat
strain. In some ways the BN rat resembles
atopic humans in their genetic predisposition
to develop allergies. Preliminary experiments
whereby ovalbumin was used as the sensitiz-
ing antigen demonstrated that the BN rat is a
promising species for the development of an
oral sensitization animal model. Furthermore,
immunoblotting experiments demonstrated
that sera from BN rats that were sensitized
orally with hen’s egg white and cow’s milk
and sera of allergic patients to hen’s egg white
or cow’s milk recognized a comparable proﬁle
of allergens in these allergic food products.
This indicates that the speciﬁc protein recog-
nition of induced antibodies in the BN rat is
comparable to that observed in sera from
allergic patients (Knippels et al. 2003).
Besides their usefulness in systemic sensi-
tization research, the BN rat and the BALB/c
mouse models exhibit many of the character-
istics of allergic asthma observed in humans:
immediate bronchial hyperresponsiveness
and increased levels of IgE antibodies in
serum and bronchoalveolar lavage ﬂuid upon
exposure to respiratory allergens such as dust
mite allergens and molds. One present limi-
tation of these models is that although many
asthma symptoms are exhibited, the animals
do not go on to develop chronic respiratory
disease, as do humans. Eventually the
rodents become tolerant to the allergen.
Several possibilities are being explored to
overcome this limitation, such as circumvent-
ing the potential for tolerance by exposing the
animals when very young.
The HLA class II transgenic mouse was
shown to be an excellent model for studying
the genetic and molecular basis of allergic
hyperresponsiveness because, like humans,
this mouse strain develops pulmonary eosino-
philia, lung tissue damage, and airway hyper-
reactivity upon exposure to allergens. This was
demonstrated by exposing the animals to
extracts of short and giant ragweed. T-cell epi-
topes were identified, and transgenic mice
with the HLA-DQ locus exhibited strong
T-cell responses to short ragweed extracts.
Only the HLA-DQ mice exhibited these
responses, indicating that a response speci-
ﬁcity exists for different HLA molecules. This
response was also mediated by CD4+ T cells.
This model holds promise for identifying epi-
topes critical in eliciting allergenic responses as
well as for developing potential immunothera-
pies (Chapoval and David 2003).
A functional in vitro assay that predicts
T-cell responses to peptide epitopes in humans
was also presented (Stickler et al. 2003). It was
specifically developed to predict functional
T-cell epitopes in individuals who had not
been previously exposed to the protein in ques-
tion. For the allergenic assessment of GM pro-
teins, this is important because previous
human exposure to most novel recombinant
proteins has never occurred. Determining the
T-cell epitopes of potentially allergenic sub-
stances may also aid in developing variants that
may be hypoallergenic, thus reducing the over-
all allergenic potential of GM proteins and
other novel substances.
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[Online 21 January 2003]Although some practical considerations
make rodents the model of choice for many
labs, several nonrodent models have proven
useful in evaluating food allergenicity. The
swine model and the atopic dog model were
described at the workshop (Helm et al.
2003). The advantage of both models lies in
their propensity to develop clinical symptoms
of food allergy, primarily gastrointestinal and
dermatologic reactions, after the sensitized
animal is challenged with food antigens. In
contrast, clinical responses to food allergens
in rodent models are not as reminiscent of
human responses.
Swine are used frequently in research as a
surrogate for humans (Helm et al. 2003).
Developing piglets have anatomic and nutri-
tional similarities to developing humans,
including a tendency to become either sen-
sitive to or tolerant of soy and cow’s milk pro-
teins. In the swine model of food allergenicity,
newborn piglets are sensitized to peanut pro-
tein by intraperitoneal injection of peanut
extract plus the adjuvant cholera, followed by
two subsequent booster injections 18 and 25
days later. Oral challenge of sensitized piglets
produces gastrointestinal and dermatologic
symptoms that can be measured with direct
skin testing to elicit wheal and ﬂare reactions
or by assessing changes in gut morphology,
including edema and hemorrhage. A limita-
tion of this model, which will undoubtedly be
overcome in the near future, is the lack of
antibodies speciﬁc for swine IgE. As a result,
the presence of food antigen-specific IgE in
sensitized animals has not yet been conﬁrmed.
Food allergy is relatively common in dogs,
affecting about 8% of the canine population
(Helm et al. 2003). The atopic dog model is
based on an inbred colony of high IgE-
producing dogs. This model has the advan-
tage that gastrointestinal and dermatologic
responses to food allergen challenge in sensi-
tized animals have been correlated with
increased circulating antigen-speciﬁc IgE. To
elicit sensitization, dogs are immunized with
live virus vaccine, followed by several subcu-
taneous injections with food antigens over a
course of weeks. At this point the dogs pro-
duce antigen-speciﬁc IgE, respond with wheal
and flare reactions in skin tests, and show
signs of gastrointestinal edema and inﬂamma-
tion. The applicability of the atopic dog
model has been proven in a study of the
potential allergenicity of a genetically modi-
ﬁed corn line. Both transgenic and nontrans-
genic corn leaf extracts were found to be
essentially nonallergenic compared with com-
mon food allergens in pups sensitized from
birth with either of the two leaf protein
extracts and with common food allergens
such as peanut, soy, and cow’s milk. These
data indicate that nonrodent models should
not be overlooked as a source of valuable data
on the potential allergenicity of genetically
modiﬁed foods.
In summary, several rodent and non-
rodent animal models of respiratory and sys-
temic sensitization with allergens are
currently been evaluated for their potential to
predict allergenicity to food, plant, and ani-
mal substances. Although presently no single
animal model meets the requirements for an
ideal animal model, each of these models has
merits that, when further validated, can con-
tribute signiﬁcantly to the overall assessment
of allergenicity to several substances including
the GM-derived protein products. The devel-
opment of in vitro assays to predict functional
T-cell epitopes in individuals who had not
been exposed previously to the culprit pro-
teins can be a very powerful tool in the study
of allergenicity to substances. Perhaps the
most useful application of this novel tech-
nique would be the development of hypoal-
lergenic substance variants. This would help
reduce the overall allergenic potential of GM
proteins and other novel substances.
REFERENCES
Chapoval SP, David CS. 2003. Identiﬁcation of antigenic epitopes
on human allergens: studies with HLA transgenic mice.
Environ Health Perspect 111:245–250.
FAO/WHO. 2001. Evaluation of Allergenicity of Genetically
Modified Foods. Report of a Joint FAO/WHO Expert
Consultation on Allergenicity of Foods Derived from
Biotechnology. Rome:Food and Agriculture Organization
of the United Nations.
Helm RM, Ermel RW, Frick OL. 2003. Nonmurine animal models
of food allergy. Environ Health Perspect 111:239–244.
Kagan RS. 2003. Food allergy: an overview. Environ Health
Perspect 111:223–225.
Kimber I, Stone S, Dearman RJ. 2003. Assessment of the
inherent allergenic potential of proteins in mice. Environ
Health Perspect 111:227–231.
Knippels LMJ, Penninks AH. 2003. Assessment of the allergic
potential of food protein extracts and proteins on oral
application using the brown Norway rat model. Environ
Health Perspect 111:233–238.
Metcalfe DD, Astwood JD, Townsend R, Sampson HA,
Taylor SL, Fuchs RL. 1996. Assessment of the allergenic
potential of foods derived from genetically engineered
crop plants. Crit Rev Food Sci Nutr 36(suppl):S165–S186.
Stickler M, Mucha, J, Estell D, Power S, Harding F. 2003. A
human dendritic cell–based method to identify CD4+ T-cell
epitopes in potential protein allergens. Environ Health
Perspect 111:251–254.
Taylor SL. 1997. Food from genetically modiﬁed organisms and
potential for food allergy. Environ Toxicol Pharmacol
4:121–126.
Mini-Monograph | Tryphonas et al.
222 VOLUME 111 | NUMBER 2 | February 2003 • Environmental Health Perspectives
EHP online articles contain convenient l li in nk ks s  t to o  P Pu ub bM Me ed d—the
National Library of Medicine’s free online search service of more than 9
million citations! Search MEDLINE and Pre-MEDLINE (including links to
other online journals and databases) for information directly related to
each EHParticle’s topic!
Subscribe to EHP today at ehponline.org
EHP PUTS EVEN MORE ENVIRONMENTAL HEALTH
INFORMATION RIGHT AT YOUR FINGERTIPS!